859
In a randomised, investigator-blinded, multicentre phase III efficacy trial, 899 infants and children with acute uncomplicated Plasmodium falciparum malaria received six doses of AL according to body weight over 3 days either as crushed tablets (Coartem) or as dispersible tablets.
 899 infants and children with acute uncomplicated Plasmodium falciparum malaria: Subject; 899: Subject.Population; infants and children: Subject.Age; six doses of AL according to body weight over 3 days either as crushed tablets (Coartem) or as dispersible tablets: Treatment; AL: Treatment.Drug; 3 days: Treatment.Duration; six doses: Treatment.Dosage; Plasmodium falciparum malaria: Treatment.Disorder; crushed tablets: Treatment.Route; dispersible tablets: Treatment.Route
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 899 infants and children with acute uncomplicated Plasmodium falciparum malaria: Subject; 899: Subject.Population; infants and children: Subject.Age; six doses of AL according to body weight over 3 days either as crushed tablets (Coartem) or as dispersible tablets: Treatment; AL: Treatment.Drug; 3 days: Treatment.Duration; six doses: Treatment.Dosage; Plasmodium falciparum malaria: Treatment.Disorder; crushed tablets: Treatment.Route; dispersible tablets: Treatment.Route